Beta Inosine Market Size, Share, Industry, Forecast and outlook (2024-2031)

Global Beta Inosine Market is segmented By  Product Type (Pharmaceutical Grade, Food Grade, Industrial Grade), By  Form (Powder, Capsules/Tablets, Liquids), By Application (Multiple Sclerosis (MS), Parkinson's Disease, Others), By End User(Healthcare and Pharmaceuticals, Food and Beverage, Biotechnology, Others) and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2024-2031

Beta Inosine Market Size

Global Beta Inosine Market reached US$ XX million in 2023 and is expected to reach US$ XX million by 2031, growing at a CAGR of XX% during the forecast period 2024-2031

Inosine, a nucleoside formed when hypoxanthine is attached to a ribose ring, is crucial for gene translation in wobble base pairs. It is found in tRNAs and has led to advancements in immunotherapy. 

Inosine monophosphate is oxidized by the enzyme inosine monophosphate dehydrogenase, producing xanthosine monophosphate, a precursor in purine metabolism. Mycophenolate mofetil, an anti-metabolite drug, inhibits inosine monophosphate dehydrogenase and is used in treating autoimmune diseases like granulomatosis with polyangiitis this is because B cells' purine uptake can exceed 8 times that of normal body cells, targeting white cells that cannot operate purine salvage pathways.

Beta Inosine Market Scope

For more details on this report Request for Sample

Beta Inosine Market Dynamics

Rise in the prevalence of parkinson’s disease

The increasing prevalence of Parkinson's disease is driving the market for inosine, a compound with potential neuroprotective effects. Inosine, metabolized to urate, has been linked to reduced risk of Parkinson's disease and slower progression. The pharmaceutical industry is investing in clinical trials and drug development programs to explore inosine's efficacy and safety for Parkinson's disease patients.

For instance, according to the Parkinson’s Foundation, around one million people in the U.S. suffer from Parkinson's disease, the second-most common neurodegenerative disease after Alzheimer's. The disease affects around 90,000 people in the U.S. annually and over 10 million worldwide. The incidence increases with age, with 4% diagnosed before age 50. Men are 1.5 times more likely to develop Parkinson's disease than women.

Side effects associated with the inosine

There are ongoing concerns regarding the safety and long-term effects of inosine supplementation, particularly at higher doses. Potential side effects and adverse reactions could lead to stricter regulations and cautious adoption . The common side effects that a individual who are on the treatment with inosine pranobex are  nausea, stomach discomfort, increased liver enzymes and blood urea nitrogen, itching, skin rashes, headaches, vertigo, fatigue or malaise (feeling unwell), joint pain. 

For more details on this report – Request for Sample

Beta Inosine Market Segment Analysis

The global beta inosine market is segmented based on product type, form, application, end-user and region.

The pharmaceutical grade from the product type segment accounted for approximately 47.3%. of the beta inosine  market share

The pharmaceutical grade from the product type segment accounted for approximately 47.3%. Pharmaceutical grade Beta Inosine is a versatile compound with several capacity therapeutic programs, specifically in areas requiring stronger energy metabolism, neuroprotection, and immune support. Its excessive purity and fineness make it suitable for use in numerous pharmaceutical formulations aimed at treating and dealing with an extensive range of health situations.

Global Beta Inosine Market Geographical Share

North America is estimated to hold about 38.4% of the total market share throughout the forecast period

North America is estimated to hold about 38.4% of the total market share throughout the forecast period owing to factors like the novel product launches, FDA approvals, advanced healthcare infrastructure in the region, collaborations and partnerships and others help the region to grow during the forecast period.

For instance, in October 2023, ZS, a global management consulting and technology firm, announced the launch of the AI-powered ZAIDYN Beta Inosine solution, part of the ZAIDYN by ZS platform. ZAIDYN Beta Inosine helps pharmaceutical companies, healthcare providers and payers innovate so they can understand unmet needs, better engage with patients and improve health outcomes. In an evolving healthcare ecosystem, it’s vital for these entities to have intelligence they can trust.

Beta Inosine Market Major Players

The major global players in the market include Merck KGaA, LGC Limited, Combi-Blocks Inc, Tokyo chemical industry, Thermo Fisher Scientific, Parchem fine & specialty chemicals, Aronis compounds, ChemTik, AK Scientific Inc among others.

Why Purchase the Report?

• To visualize the global beta inosine market segmentation based on product type, form, application, end user, and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development. 
• Excel data sheet with numerous data points of the beta inosine market level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as Excel consisting of key products of all the major players.

The global beta inosine market report would provide approximately 64 tables, 61 figures, and 186 pages.

Target Audience 2024

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies